207 related articles for article (PubMed ID: 7605997)
41. Transcription factors of the bHLH and LIM families: synergistic mediators of T cell acute leukemia?
Baer R; Hwang LY; Bash RO
Curr Top Microbiol Immunol; 1997; 220():55-65. PubMed ID: 9103675
[No Abstract] [Full Text] [Related]
42. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
Mendes RD; Sarmento LM; Canté-Barrett K; Zuurbier L; Buijs-Gladdines JG; Póvoa V; Smits WK; Abecasis M; Yunes JA; Sonneveld E; Horstmann MA; Pieters R; Barata JT; Meijerink JP
Blood; 2014 Jul; 124(4):567-78. PubMed ID: 24904117
[TBL] [Abstract][Full Text] [Related]
43. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.
Pongers-Willemse MJ; Seriu T; Stolz F; d'Aniello E; Gameiro P; Pisa P; Gonzalez M; Bartram CR; Panzer-Grümayer ER; Biondi A; San Miguel JF; van Dongen JJ
Leukemia; 1999 Jan; 13(1):110-8. PubMed ID: 10049045
[TBL] [Abstract][Full Text] [Related]
44. Site- and allele-specific polycomb dysregulation in T-cell leukaemia.
Navarro JM; Touzart A; Pradel LC; Loosveld M; Koubi M; Fenouil R; Le Noir S; Maqbool MA; Morgado E; Gregoire C; Jaeger S; Mamessier E; Pignon C; Hacein-Bey-Abina S; Malissen B; Gut M; Gut IG; Dombret H; Macintyre EA; Howe SJ; Gaspar HB; Thrasher AJ; Ifrah N; Payet-Bornet D; Duprez E; Andrau JC; Asnafi V; Nadel B
Nat Commun; 2015 Jan; 6():6094. PubMed ID: 25615415
[TBL] [Abstract][Full Text] [Related]
45. Suppression of super-enhancer-driven TAL1 expression by KLF4 in T-cell acute lymphoblastic leukemia.
Noura M; Matsuo H; Yasuda T; Tsuzuki S; Kiyoi H; Hayakawa F
Oncogene; 2024 Feb; 43(6):447-456. PubMed ID: 38102337
[TBL] [Abstract][Full Text] [Related]
46. E-box sequence and context-dependent TAL1/SCL modulation of basic helix-loop-helix protein-mediated transcriptional activation.
Nielsen AL; Norby PL; Pedersen FS; Jorgensen P
J Biol Chem; 1996 Dec; 271(49):31463-9. PubMed ID: 8940159
[TBL] [Abstract][Full Text] [Related]
47. Expression of tal-1 and GATA-binding proteins during human hematopoiesis.
Mouthon MA; Bernard O; Mitjavila MT; Romeo PH; Vainchenker W; Mathieu-Mahul D
Blood; 1993 Feb; 81(3):647-55. PubMed ID: 7678994
[TBL] [Abstract][Full Text] [Related]
48. Frequent expression of human Thy-1 antigen on pre-B cell acute lymphoblastic leukemia with t(9;22).
Takahashi T; Mizutani M; Miwa H; Katayama N; Nishii K; Shikami M; Yamaguchi M; Shiku H; Kamada N; Kita K
Int J Hematol; 1998 Jun; 67(4):369-78. PubMed ID: 9695410
[TBL] [Abstract][Full Text] [Related]
49. Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers.
Bernard M; Delabesse E; Smit L; Millien C; Kirsch IR; Strominger JL; Macintyre EA
Int Immunol; 1998 Oct; 10(10):1539-49. PubMed ID: 9796921
[TBL] [Abstract][Full Text] [Related]
50. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis.
Talora C; Cialfi S; Oliviero C; Palermo R; Pascucci M; Frati L; Vacca A; Gulino A; Screpanti I
Blood; 2006 Apr; 107(8):3313-20. PubMed ID: 16368887
[TBL] [Abstract][Full Text] [Related]
51. Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activity.
Xia Y; Hwang LY; Cobb MH; Baer R
Oncogene; 1994 May; 9(5):1437-46. PubMed ID: 8152805
[TBL] [Abstract][Full Text] [Related]
52. [Variant fusion transcripts and genomic DNA breakpoint of sil-tal1 in T-ALL cells].
Zhao XX; Liang LJ; Ding W; Li ZG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):174-9. PubMed ID: 21362246
[TBL] [Abstract][Full Text] [Related]
53. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia.
Miyamoto T; Nagafuji K; Akashi K; Harada M; Kyo T; Akashi T; Takenaka K; Mizuno S; Gondo H; Okamura T; Dohy H; Niho Y
Blood; 1996 Jun; 87(11):4789-96. PubMed ID: 8639850
[TBL] [Abstract][Full Text] [Related]
54. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts.
Onizuka T; Moriyama M; Yamochi T; Kuroda T; Kazama A; Kanazawa N; Sato K; Kato T; Ota H; Mori S
Blood; 1995 Jul; 86(1):28-37. PubMed ID: 7795234
[TBL] [Abstract][Full Text] [Related]
55. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells.
Valge-Archer VE; Osada H; Warren AJ; Forster A; Li J; Baer R; Rabbitts TH
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8617-21. PubMed ID: 8078932
[TBL] [Abstract][Full Text] [Related]
56. microRNAs regulate TAL1 expression in T-cell acute lymphoblastic leukemia.
Correia NC; Melão A; Póvoa V; Sarmento L; Gómez de Cedrón M; Malumbres M; Enguita FJ; Barata JT
Oncotarget; 2016 Feb; 7(7):8268-81. PubMed ID: 26882564
[TBL] [Abstract][Full Text] [Related]
57. SCL gene in human tumors.
Rockman S; Begley CG; Kannourakis G; Mann GJ; Dobrovic AN; Kefford RF; McGrath K
Leukemia; 1992 Jul; 6(7):623-5. PubMed ID: 1625484
[TBL] [Abstract][Full Text] [Related]
58. The basic helix-loop-helix transcription factor TAL1/SCL inhibits the expression of the p16INK4A and pTalpha genes.
Hansson A; Manetopoulos C; Jönsson JI; Axelson H
Biochem Biophys Res Commun; 2003 Dec; 312(4):1073-81. PubMed ID: 14651981
[TBL] [Abstract][Full Text] [Related]
59. Hypermethylation of p16 and p15 genes and RB protein expression in acute leukemia.
Guo SX; Taki T; Ohnishi H; Piao HY; Tabuchi K; Bessho F; Hanada R; Yanagisawa M; Hayashi Y
Leuk Res; 2000 Jan; 24(1):39-46. PubMed ID: 10634644
[TBL] [Abstract][Full Text] [Related]
60. Gradient of E2A activity in B-cell development.
Herblot S; Aplan PD; Hoang T
Mol Cell Biol; 2002 Feb; 22(3):886-900. PubMed ID: 11784864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
